Sensei Biotherapeutics (SNSE) Competitors $8.82 -0.20 (-2.16%) Closing price 09/16/2025 03:55 PM EasternExtended Trading$8.56 -0.26 (-3.00%) As of 09/16/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SNSE vs. VRCA, BRNS, CALC, TELO, GRCE, ATHE, IPSC, MDCX, LTRN, and LVTXShould you be buying Sensei Biotherapeutics stock or one of its competitors? The main competitors of Sensei Biotherapeutics include Verrica Pharmaceuticals (VRCA), Barinthus Biotherapeutics (BRNS), CalciMedica (CALC), Telomir Pharmaceuticals (TELO), Grace Therapeutics (GRCE), Alterity Therapeutics (ATHE), Century Therapeutics (IPSC), Medicus Pharma (MDCX), Lantern Pharma (LTRN), and LAVA Therapeutics (LVTX). These companies are all part of the "pharmaceutical products" industry. Sensei Biotherapeutics vs. Its Competitors Verrica Pharmaceuticals Barinthus Biotherapeutics CalciMedica Telomir Pharmaceuticals Grace Therapeutics Alterity Therapeutics Century Therapeutics Medicus Pharma Lantern Pharma LAVA Therapeutics Sensei Biotherapeutics (NASDAQ:SNSE) and Verrica Pharmaceuticals (NASDAQ:VRCA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Is SNSE or VRCA more profitable? Verrica Pharmaceuticals' return on equity of 0.00% beat Sensei Biotherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Sensei BiotherapeuticsN/A -72.13% -61.35% Verrica Pharmaceuticals N/A N/A -115.48% Do analysts recommend SNSE or VRCA? Sensei Biotherapeutics currently has a consensus target price of $55.00, indicating a potential upside of 523.23%. Verrica Pharmaceuticals has a consensus target price of $80.00, indicating a potential upside of 1,714.06%. Given Verrica Pharmaceuticals' higher probable upside, analysts plainly believe Verrica Pharmaceuticals is more favorable than Sensei Biotherapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensei Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Verrica Pharmaceuticals 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Does the media favor SNSE or VRCA? In the previous week, Sensei Biotherapeutics had 1 more articles in the media than Verrica Pharmaceuticals. MarketBeat recorded 2 mentions for Sensei Biotherapeutics and 1 mentions for Verrica Pharmaceuticals. Verrica Pharmaceuticals' average media sentiment score of 1.89 beat Sensei Biotherapeutics' score of 1.45 indicating that Verrica Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Sensei Biotherapeutics Positive Verrica Pharmaceuticals Very Positive Which has more volatility and risk, SNSE or VRCA? Sensei Biotherapeutics has a beta of 0.27, meaning that its share price is 73% less volatile than the S&P 500. Comparatively, Verrica Pharmaceuticals has a beta of 1.78, meaning that its share price is 78% more volatile than the S&P 500. Do insiders and institutionals have more ownership in SNSE or VRCA? 10.5% of Sensei Biotherapeutics shares are held by institutional investors. Comparatively, 42.5% of Verrica Pharmaceuticals shares are held by institutional investors. 23.2% of Sensei Biotherapeutics shares are held by company insiders. Comparatively, 54.0% of Verrica Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings & valuation, SNSE or VRCA? Sensei Biotherapeutics has higher earnings, but lower revenue than Verrica Pharmaceuticals. Verrica Pharmaceuticals is trading at a lower price-to-earnings ratio than Sensei Biotherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensei BiotherapeuticsN/AN/A-$30.16M-$21.31-0.41Verrica Pharmaceuticals$7.57M5.51-$76.58M-$8.28-0.53 SummaryVerrica Pharmaceuticals beats Sensei Biotherapeutics on 8 of the 15 factors compared between the two stocks. Get Sensei Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SNSE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNSE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNSE vs. The Competition Export to ExcelMetricSensei BiotherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.38M$3.12B$5.73B$10.31BDividend YieldN/A2.36%5.90%4.63%P/E Ratio-0.4121.1676.0226.51Price / SalesN/A446.35533.19123.58Price / CashN/A45.4037.1760.46Price / Book0.299.6213.806.29Net Income-$30.16M-$53.28M$3.28B$270.51M7 Day Performance2.26%1.01%0.82%1.95%1 Month Performance1.67%4.58%4.62%6.33%1 Year Performance-14.32%8.35%82.65%25.62% Sensei Biotherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNSESensei Biotherapeutics4.7028 of 5 stars$8.83-2.2%$55.00+523.2%-7.9%$11.38MN/A-0.4140Positive NewsShort Interest ↓Gap UpVRCAVerrica Pharmaceuticals4.0731 of 5 stars$4.94+4.0%$80.00+1,519.4%-76.7%$44.87M$14.70M-0.6040Positive NewsHigh Trading VolumeBRNSBarinthus Biotherapeutics2.7488 of 5 stars$1.05-4.5%$3.00+185.7%-16.7%$44.79M$14.97M-0.61107Positive NewsCALCCalciMedica2.5186 of 5 stars$2.85-10.1%$16.00+461.4%-23.3%$44.29MN/A-1.7830News CoverageShort Interest ↑High Trading VolumeTELOTelomir Pharmaceuticals2.1015 of 5 stars$1.33-2.2%$15.00+1,027.8%-78.3%$43.90MN/A-2.461GRCEGrace Therapeutics2.8984 of 5 stars$3.07-2.5%$12.00+290.9%N/A$43.56MN/A-3.57N/APositive NewsATHEAlterity Therapeutics2.5133 of 5 stars$4.64-4.9%$12.00+158.6%+242.3%$43.27MN/A0.0010News CoverageGap UpHigh Trading VolumeIPSCCentury Therapeutics2.0479 of 5 stars$0.50-0.7%$3.75+654.2%-69.2%$43.26M$6.59M-1.71170MDCXMedicus Pharma1.8006 of 5 stars$2.48+2.9%$23.50+847.6%N/A$42.94MN/A-1.85N/ALTRNLantern Pharma2.3793 of 5 stars$3.81-0.5%$25.00+556.2%+9.0%$41.36MN/A-2.1420News CoverageGap UpLVTXLAVA Therapeutics1.6402 of 5 stars$1.54-0.3%$2.69+74.4%-12.0%$40.64M$11.98M-1.4760Short Interest ↑ Related Companies and Tools Related Companies VRCA Alternatives BRNS Alternatives CALC Alternatives TELO Alternatives GRCE Alternatives ATHE Alternatives IPSC Alternatives MDCX Alternatives LTRN Alternatives LVTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNSE) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensei Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensei Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
